NeuroVive Pharmaceutical AB First Day of Trading on NASDAQ OMX Stockholm
4/10/2013 11:27:36 AM
Lund (Sweden) – April 10, 2013, NeuroVive Pharmaceutical AB (publ), a leading
mitochondrial medicine company, announces that its admission to NASDAQ OMX
Stockholm will become effective and trading of the shares will start at 09.00 am
(CET) today, 10th April 2013.